Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel
Journal cover image

Head and neck squamous cell cancer (stages III and IV) induction chemotherapy assessment: value of FDG volumetric imaging parameters.

Publication ,  Journal Article
Yu, J; Cooley, T; Truong, M-T; Mercier, G; Subramaniam, RM
Published in: J Med Imaging Radiat Oncol
February 2014

INTRODUCTION: To evaluate whether the change in the metabolic tumour volume (MTV) or total lesion glycolysis (TLG) of the primary tumour, before and after induction chemotherapy, predicts outcome for patients with advanced head and neck squamous cell cancer (SCC). METHODS: Twenty-eight patients with advanced (American Joint Committee on Cancer stage III and IV) head and neck SCC who underwent positron emission tomography (PET)/CT were included in this retrospective study. Primary tumour MTV and TLG were measured using gradient and fixed percentage threshold segmentations. Outcome endpoint was disease progression or mortality. Pearson correlation, Bland-Altman and receiver operator characteristic analysis were performed. RESULTS: The Pearson's correlation coefficients between percentage changes (pre- and post-induction chemotherapy) from gradient MTV (MTVG) and the 38% SUVmax threshold MTV (MTV38) was 0.96 and between MTVG and the 50% threshold MTV (MTV50) was 0.95 (P < 0.0001). The corresponding Pearson r between TLGG and TLG38 was 0.94 and between TLGG and TLG50 was 0.96 (P < 0.0001). The least bias was 1.89% (standard deviation = 25.30%) between the percentage changes of MTVG and MTV50. The areas under the curve for predicting progression or mortality were 0.76 (P = 0.03) for MTVG and 0.82 for TLGG (P = 0.009). Optimum cut points of a 42% reduction in MTVG and a 55% reduction in the TLGG predict event-free survival with a sensitivity of 62.5% and a specificity of 90% and a hazards ratio of 6.25. CONCLUSION: A reduction in primary tumour MTV of at least 42% or in TLG of at least 55% after induction chemotherapy may predict event-free survival in patients with advanced head and neck SCC.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Med Imaging Radiat Oncol

DOI

EISSN

1754-9485

Publication Date

February 2014

Volume

58

Issue

1

Start / End Page

18 / 24

Location

Australia

Related Subject Headings

  • Tumor Burden
  • Treatment Outcome
  • Squamous Cell Carcinoma of Head and Neck
  • Sensitivity and Specificity
  • Retrospective Studies
  • Reproducibility of Results
  • Radiopharmaceuticals
  • Radionuclide Imaging
  • Prognosis
  • Nuclear Medicine & Medical Imaging
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Yu, J., Cooley, T., Truong, M.-T., Mercier, G., & Subramaniam, R. M. (2014). Head and neck squamous cell cancer (stages III and IV) induction chemotherapy assessment: value of FDG volumetric imaging parameters. J Med Imaging Radiat Oncol, 58(1), 18–24. https://doi.org/10.1111/1754-9485.12081
Yu, Jielin, Timothy Cooley, Minh-Tam Truong, Gustavo Mercier, and Rathan M. Subramaniam. “Head and neck squamous cell cancer (stages III and IV) induction chemotherapy assessment: value of FDG volumetric imaging parameters.J Med Imaging Radiat Oncol 58, no. 1 (February 2014): 18–24. https://doi.org/10.1111/1754-9485.12081.
Yu J, Cooley T, Truong M-T, Mercier G, Subramaniam RM. Head and neck squamous cell cancer (stages III and IV) induction chemotherapy assessment: value of FDG volumetric imaging parameters. J Med Imaging Radiat Oncol. 2014 Feb;58(1):18–24.
Yu, Jielin, et al. “Head and neck squamous cell cancer (stages III and IV) induction chemotherapy assessment: value of FDG volumetric imaging parameters.J Med Imaging Radiat Oncol, vol. 58, no. 1, Feb. 2014, pp. 18–24. Pubmed, doi:10.1111/1754-9485.12081.
Yu J, Cooley T, Truong M-T, Mercier G, Subramaniam RM. Head and neck squamous cell cancer (stages III and IV) induction chemotherapy assessment: value of FDG volumetric imaging parameters. J Med Imaging Radiat Oncol. 2014 Feb;58(1):18–24.
Journal cover image

Published In

J Med Imaging Radiat Oncol

DOI

EISSN

1754-9485

Publication Date

February 2014

Volume

58

Issue

1

Start / End Page

18 / 24

Location

Australia

Related Subject Headings

  • Tumor Burden
  • Treatment Outcome
  • Squamous Cell Carcinoma of Head and Neck
  • Sensitivity and Specificity
  • Retrospective Studies
  • Reproducibility of Results
  • Radiopharmaceuticals
  • Radionuclide Imaging
  • Prognosis
  • Nuclear Medicine & Medical Imaging